# LONA (LeonaBio, Inc.) - SEC EDGAR Financial Statements

> LeonaBio, Inc. reported $38.14M in total assets and a net loss of $156.0M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/LONA
- Markdown: https://convexityos.com/fundamentals/LONA.md
- SEC CIK: 0001620463
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:04 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001620463&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$136.7M | Operating profit |
| Net Income | FY 2025 | -$156.0M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$6.57 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $32.31M | Total debt: $460K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $17.50M | $70.68M | $93.79M | $61.46M | $42.79M | $13.29M | $3.79M |
| **Operating Income** | -$102.3M | -$100.9M | -$125.5M | -$104.0M | -$64.02M | -$20.00M | -$5.45M |
| **EBITDA** | -$101.3M | -$99.93M | -$124.5M | -$103.2M | -$63.54M | -$19.99M | -$5.45M |
| Interest Expense | -- | -- | -- | -- | $3.0K | $367K | $346K |
| Income Before Tax | -- | -- | -- | -- | -- | -$19.95M | -$5.16M |
| Income Tax Expense | $0 | -- | -- | -- | -- | -- | -- |
| **Net Income** | -$105.6M | -$96.94M | -$117.7M | -$95.64M | -$54.85M | -$19.95M | -$5.16M |
| Basic EPS | -$24.70 | -$25.19 | -$30.90 | -$25.30 | -$14.90 | -$16.70 | -$14.50 |
| **Diluted EPS** | -$24.70 | -$25.19 | -$30.90 | -$25.30 | -$14.90 | -$16.70 | -$14.50 |
| Basic Shares Outstanding | 4.3M | 3.8M | 3.8M | 3.8M | 3.7M | 1.2M | 356.7K |
| Diluted Shares Outstanding | 4.3M | 3.8M | 3.8M | 3.8M | 3.7M | 1.2M | 356.7K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $15.02M | $12.70M | $11.26M | $6.71M | $2.83M | $3.66M | $4.30M | $9.37M |
| **Operating Income** | -$21.47M | -$19.45M | -$17.21M | -$78.56M | -$6.87M | -$7.29M | -$9.54M | -$15.57M |
| **EBITDA** | -$21.27M | -$19.25M | -$16.98M | -$78.32M | -$6.67M | -$7.09M | -$9.29M | -$15.32M |
| **Net Income** | -$21.16M | -$19.01M | -$32.95M | -$82.89M | -$6.61M | -$6.97M | -$9.14M | -$15.00M |
| Basic EPS | -$0.89 | -$0.80 | -$1.73 | -- | -$1.68 | -$1.78 | -$2.34 | -- |
| **Diluted EPS** | -$0.89 | -$0.80 | -$1.73 | -- | -$1.68 | -$1.78 | -$2.34 | -- |
| Basic Shares Outstanding | 23.7M | 23.7M | 19.0M | -- | 3.9M | 3.9M | 3.9M | -- |
| Diluted Shares Outstanding | 23.7M | 23.7M | 19.0M | -- | 3.9M | 3.9M | 3.9M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $69.28M | $48.44M | $90.58M | $95.97M | $110.5M | $60.62M | $2.06M |
| Short-Term Investments | $19.05M | $2.84M | $56.84M | $104.4M | $143.2M | $124.1M | -- |
| **Cash & Short-Term Investments** | $88.33M | $51.27M | $147.4M | $200.3M | $253.8M | $184.7M | $2.06M |
| **Total Current Assets** | $89.46M | $54.84M | $154.7M | $207.5M | $260.8M | $192.3M | $2.16M |
| Property, Plant & Equipment, Net | $1.47M | $2.44M | $3.39M | $4.05M | $3.76M | $2.65M | -- |
| Long-Term Investments | -- | -- | -- | $44.83M | $65.94M | $83.51M | -- |
| Other Non-Current Assets | $55K | $55K | $448K | $55K | $56K | $132K | -- |
| **Total Non-Current Assets** | $2.69M | $3.94M | $5.52M | $50.62M | $71.21M | $87.23M | $29K |
| **Total Assets** | $92.15M | $58.78M | $160.2M | $258.2M | $332.0M | $279.6M | $2.19M |
| Accounts Payable | $4.59M | $319K | $129K | $2.50M | $567K | $1.16M | $421K |
| **Total Current Liabilities** | $47.50M | $13.13M | $28.84M | $21.43M | $9.29M | $4.41M | $1.27M |
| Other Non-Current Liabilities | $1.40M | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $16.86M | $803K | $1.22M | $1.58M | $1.63M | $876K | $3.59M |
| **Total Liabilities** | $64.36M | $13.94M | $30.06M | $23.02M | $10.92M | $5.28M | $4.86M |
| **Total Debt (incl. Leases)** | $803K | $1.22M | $1.58M | $1.91M | $1.92M | $1.00M | -- |
| Common Stock | $1.0K | $0 | $4.0K | $4.0K | $4.0K | $3.0K | -- |
| Retained Earnings | -$511.8M | -$406.1M | -$309.2M | -$191.5M | -$95.89M | -$41.04M | -$21.09M |
| Accumulated Other Comp. Income | -$4.0K | $1.0K | -$349K | -$1.96M | -$388K | $33K | -- |
| **Total Stockholders' Equity** | $27.79M | $44.84M | $130.2M | $235.1M | $321.1M | $274.3M | -$19.72M |
| Total Equity | $27.79M | $44.84M | $130.2M | $235.1M | $321.1M | $274.3M | -$19.72M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $16.34M | $32.32M | $32.83M | $69.28M | $20.87M | $19.89M | $26.42M | $48.44M |
| Short-Term Investments | $15.97M | $18.74M | $34.85M | $19.05M | $4.35M | $9.94M | $10.25M | $2.84M |
| **Cash & Short-Term Investments** | $32.31M | $51.07M | $67.68M | $88.33M | $25.23M | $29.82M | $36.67M | $51.27M |
| **Total Current Assets** | $36.33M | $54.81M | $69.20M | $89.46M | $27.02M | $32.22M | $39.85M | $54.84M |
| Property, Plant & Equipment, Net | $800K | $1.01M | $1.24M | $1.47M | $1.72M | $1.96M | $2.20M | $2.44M |
| Other Non-Current Assets | $64K | $55K | $55K | $55K | $55K | $62K | $85K | $55K |
| **Total Non-Current Assets** | $1.80M | $2.09M | $2.39M | $2.69M | $3.01M | $3.33M | $3.66M | $3.94M |
| **Total Assets** | $38.14M | $56.89M | $71.59M | $92.15M | $30.03M | $35.55M | $43.51M | $58.78M |
| Accounts Payable | $788K | $2.42M | $1.76M | $4.59M | $266K | $171K | $867K | $319K |
| **Total Current Liabilities** | $7.33M | $7.82M | $6.67M | $47.50M | $2.79M | $2.98M | $5.49M | $13.13M |
| Other Non-Current Liabilities | $840K | $1.03M | $1.22M | $1.40M | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $14.79M | $15.48M | $15.62M | $16.86M | $460K | $578K | $691K | $803K |
| **Total Liabilities** | $22.12M | $23.30M | $22.29M | $64.36M | $3.25M | $3.56M | $6.18M | $13.94M |
| **Total Debt (incl. Leases)** | $460K | $577K | $691K | $803K | $912K | $1.02M | $1.12M | $1.22M |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $4.0K | $4.0K | $4.0K | $0 |
| Retained Earnings | -$584.9M | -$563.7M | -$544.7M | -$511.8M | -$428.9M | -$422.3M | -$415.3M | -$406.1M |
| Accumulated Other Comp. Income | -$12K | -$9.0K | -$13K | -$4.0K | -$2.0K | -$3.0K | -$4.0K | $1.0K |
| **Total Stockholders' Equity** | $16.02M | $33.59M | $49.30M | $27.79M | $26.79M | $31.99M | $37.33M | $44.84M |
| Total Equity | $16.02M | $33.59M | $49.30M | $27.79M | $26.79M | $31.99M | $37.33M | $44.84M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$105.6M | -$96.94M | -$117.7M | -$95.64M | -$54.85M | -$19.95M | -$5.16M |
| Depreciation & Amortization | $972K | $970K | $969K | $845K | $479K | $2.0K | $2.0K |
| Stock-Based Compensation | $6.10M | $11.05M | $10.62M | $10.61M | $4.62M | $633K | $253K |
| **Operating Cash Flow** | -$45.73M | -$97.17M | -$100.8M | -$72.47M | -$43.10M | -$24.11M | -$3.71M |
| Capital Expenditure | -- | -$33K | -$304K | -$1.14M | -$1.57M | -$2.32M | -- |
| **Free Cash Flow** | -- | -$97.20M | -$101.1M | -$73.61M | -$44.67M | -$26.43M | -- |
| Purchases of Investments | -$37.64M | -$14.13M | -$27.67M | -$95.29M | -$299.2M | -$226.8M | -$995K |
| Sales & Maturities of Investments | -- | -- | -- | -- | $296.7M | $38.11M | -- |
| **Investing Cash Flow** | -$15.89M | $54.83M | $95.09M | $57.66M | -$4.08M | -$210.1M | $1.51M |
| Common Stock Issued | $89.99M | -- | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $82.46M | $194K | $493K | $654K | $97.09M | $292.8M | $946K |
| **Net Change in Cash** | $20.84M | -$42.15M | -$5.17M | -$14.15M | $49.91M | $58.57M | -$1.26M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$21.16M | -$19.01M | -$32.95M | -$82.89M | -$6.61M | -$6.97M | -$9.14M | -$15.00M |
| Depreciation & Amortization | $200K | $200K | $231K | $243K | $200K | $200K | $243K | $243K |
| Stock-Based Compensation | $3.59M | $3.18M | $662K | $1.46M | $1.41M | $1.60M | $1.64M | $2.23M |
| **Operating Cash Flow** | -$18.89M | -$16.96M | -$20.90M | -$19.40M | -$4.67M | -$7.00M | -$14.66M | -$26.01M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -- | -$26.01M |
| Purchases of Investments | -$7.97M | -$10.22M | -$20.61M | -$18.04M | -$3.34M | -$6.07M | -$10.20M | -$2.81M |
| **Investing Cash Flow** | $2.91M | $16.33M | -$15.54M | -$14.64M | $5.65M | $441K | -$7.35M | -$2.81M |
| **Net Change in Cash** | -$15.99M | -$510K | -$36.44M | $48.40M | $986K | -$6.53M | -$22.02M | -$28.79M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -380.0% | -216.2% | -90.4% | -40.7% | -17.1% | -7.3% | -- |
| Return on Assets (ROA) | -114.6% | -164.9% | -73.4% | -37.0% | -16.5% | -7.1% | -235.8% |
| Current Ratio | 1.88x | 4.18x | 5.37x | 9.68x | 28.07x | 43.66x | 1.70x |
| Quick Ratio | 1.86x | 3.90x | 5.11x | 9.35x | 27.31x | 41.93x | 1.62x |
| Debt to Equity | 0.03x | 0.03x | 0.01x | 0.01x | 0.01x | 0.00x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -974.0% | -421.1% | -262.5% | -380.0% | -140.8% | -187.1% | -213.6% | -216.2% |
| Return on Assets (ROA) | -409.1% | -248.6% | -180.8% | -114.6% | -125.6% | -168.4% | -183.3% | -164.9% |
| Current Ratio | 4.96x | 7.01x | 10.38x | 1.88x | 9.70x | 10.81x | 7.26x | 4.18x |
| Quick Ratio | 4.41x | 6.53x | 10.15x | 1.86x | 9.05x | 10.00x | 6.68x | 3.90x |
| Debt to Equity | 0.03x | 0.02x | 0.01x | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
